Edwards Lifesciences
1,235 hedge funds and large institutions have $37.2B invested in Edwards Lifesciences in 2023 Q4 according to their latest regulatory filings, with 170 funds opening new positions, 375 increasing their positions, 497 reducing their positions, and 130 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,235
Holders Change
+24
Holders Change %
+1.98%
% of All Funds
18.11%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.13%
New
170
Increased
375
Reduced
497
Closed
130
Calls
$336M
Puts
$232M
Net Calls
+$104M
Net Calls Change
-$34M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$931M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$572M |
| 3 |
JPMorgan Chase & Co
New York
|
$597M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
$1.39B |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
$263M |
